← Back
product
Liraglutide
Last discussed Sep 28, 2026
A GLP-1 receptor agonist (brand names Victoza, Saxenda) that has been on the market longer than newer GLP-1 drugs, used for diabetes and weight management.
Recently discussed in
409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles
Lloyd B. Klickstein · Sep 28, 2026
What We Got Wrong About GLP-1s (And What's Actually Right)
Tyna Moore · Aug 12, 2026
What creators say
LB
Lloyd B. Klickstein
mentioned
Used for: Combination with Bagramab for obesity treatment in mouse studies
vs: Tested alongside semaglutide and tirzepatide
"The efficacy was additive when you took Bagramab with semaglutide or tirzepatide or liraglutide. It did them all."
More from Lloyd B. Klickstein →
TM
Tyna Moore
mentioned
Praised: Long track record without cancer-related mortality
vs: Mentioned alongside exenatide as older GLP-1 drugs with established long-term...
"We do know we have had liraglutide and exenatide out for a long time and nobody's dying of cancer from those."
More from Tyna Moore →About this data
- ✓44,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it